
Let's Talk Business
Our Mission
SereneKID strives to enhance the quality of life for families and elevate the academic performance of their children.
We are currently fundraising
We are open for equity investments into our company. Current friends-and-family round of investment will be held at very favorable valuation and based on the readiness level of our product may be the only round we need. Contact us through the form below to start the conversation. Investor Deck is available per your request.
We all know parents who struggle with their children's impulsiveness, fidgeting, lack of focus, and overall loud behavior. This is such a common occasion that you may be one of those parents.
The core idea of SereneKID technology is to speed up the development of brain mechanisms that help control excitement and behavior without using any physical methods. The device promotes formation of a mature brain structure, ultimately restoring normal behavior in the child, including their movements, attention, and learning abilities.
This makes our product and offer very enticing. Who does not want a more mature and focused child, who can concentrate during studying and produce better results in school?

SereneKID Offers following Results:
-
Enhanced Focus
-
Improved Concentration
-
Behavioral Stability
-
Improved Learning Abilities
-
Better Performance in School
SereneKID Device Features:
-
Uses light motivational incentives
-
Adaptive learning algorithm
-
Real-Time Progress Monitoring
-
Non-Invasive and Harmless to a Child
-
Ability for a Child to Use The Device on their own
-
Visible outcomes in 2-3 weeks
-
Improvement You see on the Screen and Feel Life

Solves Widely Occuring Problem

Simple and Predictable Business

Technology that
Just Works

No Direct Competition Worldwide

Highly Attractive Topic for Parents

Scalable Manufacturing w/ Low Production Cost
No Direct Competition Worldwide
For children diagnosed with ADHD, behavior correction is typically managed by psychologists or psychotherapists using two main approaches:
- Drug Therapy: Involving medications like Strattera, Ritalin, Adderall, etc.
- Neuropsychological (Behavioral) Therapy.
We aim at a substantial market segment, and the focus of our initial marketing efforts, consists of children not diagnosed with ADHD but those causing persistent negative emotions and frustration in their parents.
The existing solution for this group involves specialized kindergartens or groups with increased psychological involvement for behavior correction. However, this option is not only expensive but also proves ineffective, as reflected in reviews from parent communities online.
Crucially, there are no specialized technologies or devices comparable to SereneKID for independent use by parents, highlighting a significant gap in the market that our innovative solution aims to fill.
Large Servicable Addressable Market

Case Studies
During the development of the technology the team has run a set of trials on children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Below are some cases and the results of working with SereneKID device prototype.
The graph illustrates the average GMA (General Motor Activity) value per session. Connecting these data points is a dashed line that represents the outcomes of the Schulte proofreading test. This test, a standard measure of attention, was conducted prior to the training sessions.
Current Readiness Level
-
Currently we are in posession of 100 devices ready to be shipped to our customers.
-
Apps are ready and in review by Apple and Google app stores.
-
Quickstart Guide and Extended Operational Manual are completed.
-
Advertising starts in November regardless of procured investment.
-
We continue sending out samples for testing to our friends.
-
Product packaging needs to be improved.
Timeline of what is to be

1 - 5
Months
Kickstarter prep, product presale, and campaign completion.

Months
6 - 9
Marketing and sales. Product case/packaging redesign.

10 - 15
Months
Ramp-up in production of redesigned device. COGS down.

Months
16 - 20
FDA Application. Increase in international marketing efforts.

21 - X
Months
FDA Approval. Business re-evaluation with optional investor exit.
Timeline of what has been

1988
Creation of recording techniques and algorithms for the analysis of motor behavior in laboratory animals, development of a piezoelectric sensor, conducted at the Institute of Experimental Medicine in St. Petersburg.

1999
Building upon the research and technological innovation, the team engaged in studies aimed at minimizing tremors in neurological patients diagnosed with Parkinson's disease.


